Literature DB >> 26057372

A 47-year-old stem cell transplant recipient with fever, cough and chest pain.

Omar S Salh, Omar N Nadhem, Sanket R Thakore, Ruba A Halloush, Faisal A Khasawneh.   

Abstract

Infections and malignancies are among the most serious complications that follow organ or stem cell transplantation. They may have a mild course, and nonspecific and overlapping manifestations. The present article describes a case of symptomatic nodular pulmonary disease that complicated hematopoietic stem cell transplantation. It was diagnosed to be post-transplant lymphoproliferative disorder, a potential sequela of immunosuppression and a very difficult entity to treat in profoundly immunosuppressed patients.

Entities:  

Mesh：

Year:  2015        PMID： 26057372      PMCID： PMC4470546          DOI： 10.1155/2015/132162

Source DB:  PubMed          Journal:  Can Respir J        ISSN： 1198-2241            Impact factor:   2.409


  16 in total

1.  De novo malignances in pediatric organ transplant recipients.

Authors:  I Penn
Journal:  Pediatr Transplant       Date:  1998-02

2.  Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).

Authors:  S H K Oertel; E Verschuuren; P Reinke; K Zeidler; M Papp-Váry; N Babel; R U Trappe; S Jonas; M Hummel; I Anagnostopoulos; B Dörken; H B Riess
Journal:  Am J Transplant       Date:  2005-12       Impact factor: 8.086

3.  Thoracic presentations of posttransplant lymphoproliferative disorders.

Authors:  Michael E Halkos; Joseph I Miller; Karen P Mann; Daniel L Miller; Anthony A Gal
Journal:  Chest       Date:  2004-12       Impact factor: 9.410

4.  Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

Authors:  R E Curtis; L B Travis; P A Rowlings; G Socié; D W Kingma; P M Banks; E S Jaffe; G E Sale; M M Horowitz; R P Witherspoon; D A Shriner; D J Weisdorf; H J Kolb; K M Sullivan; K A Sobocinski; R P Gale; R N Hoover; J F Fraumeni; H J Deeg
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

Review 5.  Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.

Authors:  Nishitha Reddy; Katayoun Rezvani; A John Barrett; Bipin N Savani
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-21       Impact factor: 5.742

Review 6.  Hodgkin lymphoma-like posttransplantation lymphoproliferative disorder.

Authors:  Barbara Semakula; Jon V Rittenbach; Jun Wang
Journal:  Arch Pathol Lab Med       Date:  2006-04       Impact factor: 5.534

7.  Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

Authors:  Ralf Trappe; Stephan Oertel; Veronique Leblond; Peter Mollee; Monica Sender; Petra Reinke; Ruth Neuhaus; Hans Lehmkuhl; Heinz August Horst; Gilles Salles; Franck Morschhauser; Arnaud Jaccard; Thierry Lamy; Malte Leithäuser; Heiner Zimmermann; Ioannis Anagnostopoulos; Martine Raphael; Hanno Riess; Sylvain Choquet
Journal:  Lancet Oncol       Date:  2011-12-13       Impact factor: 41.316

8.  Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?

Authors:  S Ranganathan; S Webber; S Ahuja; R Jaffe
Journal:  Pediatr Dev Pathol       Date:  2004-06-17

9.  Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.

Authors:  M Benkerrou; J P Jais; V Leblond; A Durandy; L Sutton; P Bordigoni; J L Garnier; J Le Bidois; F Le Deist; S Blanche; A Fischer
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

10.  Prompt versus preemptive intervention for EBV lymphoproliferative disease.

Authors:  Hans-Joachim Wagner; Yee Chung Cheng; M Helen Huls; Adrian P Gee; Ingrid Kuehnle; Robert A Krance; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop
Journal:  Blood       Date:  2004-01-29       Impact factor: 22.113
View more
  1 in total

1.  Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall.

Authors:  Taro Mohri; Yoshihiro Ikura; Asako Hirakoso; Masashi Okamoto; Masakatsu Hishizawa; Akifumi Takaori-Kondo; Seiichi Kato; Shigeo Nakamura; Kai Yoshimura; Hidetoshi Okabe; Yasuhiro Iwai
Journal:  Int J Hematol       Date:  2018-01-29       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.